A Phase 1, Multiple Intravenous Dose Study to Examine Safety, Tolerability, and PK of Intravenous TD-8954, a 5-HT4 Receptor Agonist, in Healthy Subjects

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions

Gastrointestinal Motility Disorder

Interventions

DRUG

TD-8954

Intravenous infusion

DRUG

Placebo - saline

Intravenous infusion

Trial Locations (1)

Miami Research Associates, Miami